Innovative Medicine — Impairment of intangible assets, excluding goodwill
Business Segments · Impairment of intangible assets, excluding goodwillJohnson & Johnson Innovative Medicine — Impairment of intangible assets, excluding goodwill remained flat by 0.0% to $50.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $50.00M to $50.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ4 2024
How to read this metric
An increase signals potential failure in R&D projects or overpayment for acquired assets, which is a negative indicator.
Detailed definition
This metric reflects the write-down of the carrying value of specific intangible assets, such as patents, licenses, or i...
Peer comparison
Standard risk metric for R&D-heavy pharmaceutical companies evaluating their intangible asset portfolios.
Metric ID:
jnj_segment_innovative_medicine_impairment_of_intangible_assets_excluding_goodwillHistorical Data
2 years
| FY'23 | FY'24 | |
|---|---|---|
| Value | $200.00M | $200.00M |
| YoY Change | — | +0.0% |
Range$200.00M – $200.00M
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's innovative medicine — impairment of intangible assets, excluding goodwill?
- Johnson & Johnson (JNJ) reported innovative medicine — impairment of intangible assets, excluding goodwill of $50.00M in Q4 2024.
- How has Johnson & Johnson's innovative medicine — impairment of intangible assets, excluding goodwill changed year-over-year?
- Johnson & Johnson's innovative medicine — impairment of intangible assets, excluding goodwill decreased by 0.0% year-over-year, from $50.00M to $50.00M.
- What does innovative medicine — impairment of intangible assets, excluding goodwill mean?
- The loss in value recognized when specific pharmaceutical patents or licenses are deemed less valuable than previously recorded.